Key takeaways Semaglutide is a weekly injectable medication for type 2 diabetes, obesity, and some forms of heart disease, administered subcutaneously in the stomach, thigh, or upper arm
The most popular trial for Ozempic was the SUSTAIN-6 trial published in 2016, which showed that participants receiving weekly Ozempic (semaglutide) lost an average of 3-5 kg (8-11 lbs) after two years (3)
Additionally, on a monthly basis, we will assess your weight, waist measurement, BMI (body mass index), BMR (basal metabolic rate), and blood pressure to monitor your advancements and make any necessary adjustments
For athletes, bodybuilders, or aging individuals seeking improvements in recovery, fat loss, lean muscle retention, and sleep quality , it provides one of the most refined and well-tolerated peptide options available today
The letter stated that MEDVi's labeling and website implied MEDVi itself compounded the medication, which it does not, since production runs through a separate pharmacy partner